America’s premier transplant program features world-renowned physicians, better survival rates, and innovative approaches.
The transplant program at NewYork-Presbyterian, Columbia, and Weill Cornell Medicine is among the longest established and most experienced program in the country. Due to their experience and expertise, our physicians can confidently care for some of the most complex transplants, including multi-organ transplants. Patients come to us from across the country and around the world for better outcomes and innovative procedures that allow for quicker access to transplants and also quicker recovery.
Liver Transplantation Offers a Promising Option for Colorectal Cancer Liver Metastases
Weill Cornell Medicine physicians are leading cutting-edge treatments for patients with colorectal cancer liver metastases (CRLM).
Dr. Joshua Weiner: A Revolutionary Pathway to Achieve Better Tolerance in Kidney Transplantation
A Columbia transplant surgeon shares his perspective on the groundbreaking PANORAMA trial and the future of kidney transplantation.
Multidisciplinary Care Team Performs First-Ever Infant Domino Partial Heart Transplant
An integrated team of Columbia cardiologists and cardiothoracic surgeons perform a full heart transplant and concurrent living allogeneic heart valve transplant to save two babies’ lives.
Clinician Identifies the Risks and Outcomes of Patients With Hematologic Disorders Undergoing Heart Transplant
A Columbia cardiologist shows that people with hematologic disorders have an increased risk of certain complications after transplant surgery but the same survival rates as those without these conditions.
Total Artificial Heart Revolutionizes Heart Transplant Surgery
A Columbia cardiothoracic surgeon performs a total artificial heart implant in the first pediatric patient in the northeast.
Antivirals and Organ Transplant Recipients: Experts Offer Management Recommendations
Weill Cornell Medicine and Columbia specialists in organ transplantation offer guidelines in managing clinically significant drug-drug interactions with Paxlovid and transplant immunosuppressants.
Championing Innovative Strategies in Living Donor Kidney Transplantation
NewYork-Presbyterian Leads Efforts to Increase Utilization of Split Liver Transplant in U.S.
We are leading efforts to increase the utilization of split liver transplantation, including training surgeons, conducting research to show outcomes from SLT are not inferior, and helping to change policy around allocation and scoring.
Centralized Heart Failure Management Program Using Remote Monitoring, Artificial Intelligence
Led by Nir Uriel and Gabriel Sayer, NewYork-Presbyterian developed a 5-phase approach to identify patients with worsening heart failure who may benefit from heart failure management in between clinic visits.
Physicians Examine the Safety and Efficacy of Tocilizumab for the Treatment of Severe COVID-19 Infection
Researchers at NewYork-Presbyterian/
Liver Paired Exchange Program
As the U.S. continues to face a major organ shortage, liver experts consider innovative methods to increase the number of liver allografts. A liver paired exchange program could expand the pool for patients with ABO incompatible and size mismatched living donors.
COVID-19 Lung Transplant Recipient Case Series
In the largest, single-center retrospective case series of lung transplant recipients infected with COVID-19 to date, the Lung Transplant Program at NewYork-Presbyterian/
COVID-19 Infection in Patients Waitlisted for Kidney Transplantation and Kidney Transplant Recipients
Researchers at NewYork-Presbyterian/
COVID-19 Infection in Kidney Allograft Recipients
In a retrospective chart review of 54 kidney transplant recipients infected with COVID-19, researchers at NewYork-Presbyterian/
COVID-19 All Solid Organ Transplant Recipient Cohort Study
In a collaborative effort between NewYork-Presbyterian/
COVID-19 Experience of NewYork-Presbyterian/Columbia’s Kidney Transplant Program
In a series of 6 recently published papers, NewYork-Presbyterian/
Lung Transplantation: Decades of Experience and Expertise
Since the inception of the program nearly two decades ago, the Lung Transplantation Program at NewYork-Presbyterian/
Management of Heart Transplant Recipients Infected With SARS-COV2
Heart transplant recipients with COVID-19 are at high risk for severe complications. The researchers, led by Nir Uriel, MD, MSc, discuss implications for the management of SARS-COV2, given the need for immunosuppression in this patient population.
Living Donor Liver Transplant
As one of 20 centers in the United States who perform more than 20 living donor liver transplants per year, NewYork-Presbyterian is helping to expand the donor pool by advocating for living donations.
Newsletters for Medical Professionals
2023 Issue 1
- NewYork-Presbyterian Clinician Identifies the Risks and Outcomes of Patients With Hematologic Disorders Undergoing Heart Transplant
- Physician Story: Championing Innovative Strategies in Living Donor Kidney Transplantation
- Antivirals and Organ Transplant Recipients: Experts Offer Management Recommendations